Trial Profile
A study of Dexamethasone (DexNP) for the treatment of corneal neovascularisation
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 02 Sep 2016
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Corneal neovascularisation
- Focus Therapeutic Use
- 02 Sep 2016 New trial record